S-349572 GSK1349572 BDBM50062551 CHEBI:76010 Dolutegravir
CHEBI:76007 Tivicay GSK1349572 Dolutegravir Sodium GSK1349572A BDBM50483553
- Reese, MJ; Savina, PM; Generaux, GT; Tracey, H; Humphreys, JE; Kanaoka, E; Webster, LO; Harmon, KA; Clarke, JD; Polli, JW In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor. Drug Metab Dispos 41: 353-61 (2013)
- Johns, BA; Kawasuji, T; Weatherhead, JG; Taishi, T; Temelkoff, DP; Yoshida, H; Akiyama, T; Taoda, Y; Murai, H; Kiyama, R; Fuji, M; Tanimoto, N; Jeffrey, J; Foster, SA; Yoshinaga, T; Seki, T; Kobayashi, M; Sato, A; Johnson, MN; Garvey, EP; Fujiwara, T Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744). J Med Chem 56: 5901-16 (2013)